当前位置: 首页 >> 检索结果
共有 83393 条符合本次的查询结果, 用时 1.8105587 秒

661. The Meningitis Vaccine Appears to Protect Against Gonorrhea-Scientists May Now Know Why.

作者: Samantha Anderer.
来源: JAMA. 2025年334卷5期377-378页

662. Pandemic Exacerbated Rise in Alcohol-Associated Liver Disease Deaths.

作者: Samantha Anderer.
来源: JAMA. 2025年334卷5期384页

663. Collection Kits Boost Cervical Cancer Screening.

作者: Samantha Anderer.
来源: JAMA. 2025年334卷5期384页

664. Social Robots That Help Support People's Health Are Getting a Boost From AI.

作者: Jennifer Abbasi.
来源: JAMA. 2025年334卷5期379-382页

665. US Overdose Deaths Are Declining but Inequities Persist.

作者: Samantha Anderer.
来源: JAMA. 2025年334卷5期383页

666. FDA Approves New RSV Monoclonal Antibody to Protect Infants.

作者: Samantha Anderer.
来源: JAMA. 2025年334卷5期383页

667. Combining Coronary Calcium Score With Treatment in Familial Coronary Artery Disease.

作者: Anshul Yadav.;Muhammad Shariq Usman.;Rajeev Gupta.
来源: JAMA. 2025年334卷5期454页

668. Combining Coronary Calcium Score With Treatment in Familial Coronary Artery Disease-Reply.

作者: Thomas H Marwick.;Kristyn Whitmore.;Stephen J Nicholls.; .
来源: JAMA. 2025年334卷5期454-455页

669. HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results.

作者: Kristen M Marks.;Minhee Kang.;Triin Umbleja.;Andrea Cox.;Karen J Vigil.;Anchalee Avihingsanon.;Patcharaphan Sugandhavesa.;Leolin Katsidzira.;Josphat Kosgei.;Hugo Perazzo.;Jennifer Price.;Stephanie Caruso.;Kevin Knowles.;Beverly L Alston-Smith.;Parita Rathod.;Kenneth E Sherman.; .
来源: JAMA. 2025年334卷10期910-912页

670. Nirmatrelvir-Ritonavir Access and Hospitalizations and Mortality in Older Adults-Reply.

作者: John N Mafi.;Sitaram Vangala.;Katherine L Kahn.
来源: JAMA. 2025年334卷5期455-456页

671. Promoting Healthy Aging in People With HIV-Into a New Era.

作者: Lauren F Collins.;Solveig A Cunningham.;Camille P Vaughan.;Ighovwhera Ofotokun.
来源: JAMA. 2025年334卷5期387-388页

672. Management of Peripheral Artery Disease.

作者: Aman Kansal.;Andrew M Davis.;Jennifer A Rymer.
来源: JAMA. 2025年334卷5期444-445页

673. Nirmatrelvir-Ritonavir Access and Hospitalizations and Mortality in Older Adults.

作者: Wendong Hao.
来源: JAMA. 2025年334卷5期455页

674. The MAHA Commission Report and Diet-Related Diseases in Youth.

作者: Dariush Mozaffarian.;Emily A Callahan.;William H Frist.
来源: JAMA. 2025年334卷6期487-488页

675. Osteoporosis: A Review.

作者: Suzanne N Morin.;William D Leslie.;John T Schousboe.
来源: JAMA. 2025年334卷10期894-907页
Osteoporosis is characterized by low bone mass, increased bone fragility, and increased susceptibility to fracture, which is associated with substantial morbidity, mortality, and economic costs. Worldwide, 1 in 3 women and 1 in 5 men older than 50 years of age experience osteoporotic fractures in their lifetime.

676. Prevalence and Control of Diabetes Among US Adults.

作者: Feng Xu.
来源: JAMA. 2025年334卷5期453页

677. Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial.

作者: Manish Saxena.;Luke Laffin.;Claudio Borghi.;Beatriz Fernandez Fernandez.;Jalal K Ghali.;Branko Kopjar.;Krishna Polu.;Simon D Roger.;B T Slingsby.;Frank Strutz.;Liffert Vogt.;Matthew R Weir.;David Rodman.; .
来源: JAMA. 2025年334卷5期409-418页
Uncontrolled hypertension remains a global health concern and dysregulated aldosterone production is a central mechanism. Lorundrostat, a novel aldosterone synthase inhibitor that reduces aldosterone production, demonstrated efficacy in participants with uncontrolled hypertension, including those with treatment-resistant hypertension.

678. Prevalence and Control of Diabetes Among US Adults-Reply.

作者: Kosuke Inoue.;Michael Liu.;Rishi K Wadhera.
来源: JAMA. 2025年334卷5期453-454页

679. Study Shows Decline in Hypertension Awareness Among US Adults.

作者: Samantha Anderer.
来源: JAMA. 2025年334卷4期295页

680. Valley Fever Likely Vastly Underreported.

作者: Samantha Anderer.
来源: JAMA. 2025年334卷4期296页
共有 83393 条符合本次的查询结果, 用时 1.8105587 秒